Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Supplementary Table 1 from Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen–Positive Advanced/Metastatic Solid Tumors

Melero I., Tabernero J., Steeghs N., Robbrecht DGJ., Peters S., Rizvi NA., O’Reilly EM., Calvo E., Eefsen RL., Leighl N., Cervantes A., Hafez N., Habigt C., Andersson E., Dejardin D., Rossmann E., Martinez Quetglas I., Babitzki G., Duarte J., Adessi C., Boetsch C., Evers S., Charo J., Teichgräber V., Lassen U.

Table S1